The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...
Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...
Global sustainable funds faced net outflows of approximately USD 55 billion in Q3 2025, a sharp reversal from the USD 5.8 billion inflows in the previous quarter. This shift was driven primarily by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback